Beckman 1988
Beckman 1988
Beckman 1988
6884-6892, 1988
0 1988 by The American Society for Biochemistry and Molecular Biology, Inc Printed in U.S.A.
Joseph S. Beckman$, RobertL. Minor, Jr.5, Carl W. Whiten, John E. Repinell, Gerald M. Rosenil,
and BruceA. Freeman$
From the $Departments of Anesthesiology and Biochemistry, University of Alabama at Birmingham, University Station,
Birmingham, Alabama 35233, the §School of Medicine, University of Iowa, Iowa City, Iowa 52242, the ll Webb-Waring Lung
Institute, University of Colorado Health Sources Center, Denver, Colorado 80302, and the 11 Department of Pharmacology,
Duke University Medical Center, Durham, North Carolina 27710
Covalent conjugation of superoxide dismutase and drugs, radiation exposure, and ischemia (2, 3), has also stim-
catalase with polyethyleneglycol (PEG) increases the ulated the use of antioxidant enzymes as therapeutic agents.
circulatory half-lives of these enzymes from <lo min However, the experimental and therapeutic potentialsof su-
to 40 h, reduces immunogenicity, and decreases sensi- peroxide dismutase and catalase are limited by two factors.
tivity to proteolysis. Because PEG has surface active First, both proteins are rapidlycleared by kidneys (4,5 ) ,
properties and can induce cell fusion, wehypothesized leading to circulatory half-lives of only 6-10 min following
that PEG conjugation could enhance cell binding and intravenous injection. Second, reactive oxygen species diffuse
association of normally membrane-impermeable en- very short distancesbefore reacting with cellular components
zymes. Incubation of cultured porcine aortic endothe- (6), and neithersuperoxide dismutase nor catalase can pene-
lial cells with lZ6I-PEG-catalaseor ‘261-PEG-superox- trate across cell membranes. Thus, antioxidant enzymes can
idedismutaseproduceda linear,concentration-de-
pendentincreaseincellularenzymeactivityand not gain access to intracellular sitesof free radical generation
radioactivity. Fluorescently labeled PEG-superoxide to achieve effective pharmacological value.
dismutase incubated with endothelial cells showed a The renal clearance of superoxide dismutase and catalase
vesicular localization. Mechanical injury tocell mono- can be prevented by increasing theirmolecular weight through
layers, which is known to stimulate endocytosis, fur- covalent attachment of the inert linear polymer, monome-
ther increased the uptake of fluorescent PEG-super- thoxy-polyethylene glycol (PEG;’ Refs. 7-9). The structureof
oxide dismutase. Endothelial cell cultures incubated PEG isH-0-(CH,-CH,-0)”-CH, with n = 150 forPEG weigh-
with PEG-superoxide dismutase and PEG-catalase for ing 5000 Da. The free hydroxyl of PEG is conjugated to t-
24 h and then extensively washed were protected from amino groups of lysine with a bifunctional reagent such as
the damaging effects of reactive oxygen species de- cyanuric chloride. Typically, from 10 to15 of the 20 available
rived from exogenous xanthine oxidase as judged by amino groups on superoxide dismutase aremodified with PEG
two criteria: decreased release of intracellular W r - monomers of a n average molecular mass of 5000 Da each,
labeled proteins and free radical-induced changes in increasing the molecular mass of superoxide dismutase from
membrane fluidity, measured by electron paramag- 32 kDa to about100 kDa for the modified protein. Similarly,
netic resonance spectroscopyof endothelial membrane the molecular weight of catalase may be increased by 300%
proteins covalently labeledwith 4-maleimido-2,2,6,6- following PEG conjugation. Modificationby PEG blocks renal
tetramethylpiperidinooxyl.Addition of PEG andPEG- clearance and increases the circulating enzyme half-life from
conjugated enzymes perturbed the spin-label binding 6 min to 30-40 h in the rat(9). The inert natureof PEG also
environment, indicative of producing an increase in reduces the antigenicityof the native protein and inhibits the
plasma membrane fluidity. Thus, PEG conjugation to hydrolysis of protease-sensitive proteins such as catalase(8).
superoxide dismutase and catalase enhances cell asso- Additionally, the long term stability of enzymes in aqueous
ciation of these enzymes in a manner which increases
cellular enzyme activities and provides prolonged pro- solution is frequently increasedby PEG conjugation.
tection from partially reduced oxygen species. Polyethylene glycol is a surface-active molecule that is used
extensively to induce fusion for cell hybridization (10). Mem-
branes can absorb substantial quantities of PEG, binding 1
PEG molecule/l2 dipalmitoyl-phosphatidylcholine molecules
Controlled manipulation of cellular superoxide dismutase- in liposomes with a dissociation constant of 6 p M (11).Be-
and catalase-specific activities can help
define mechanisms of cause PEG constitutes up to two-thirds of the totalmolecular
tissue injury mediated by superoxide and hydrogen peroxide weight of PEG-conjugated enzymes, we have investigated the
(1).The toxicity of reactive oxygen species, whose rate of possible membrane association of PEG-conjugated enzymes
production can be amplified by pathological events including with cultured endothelialcells. Endothelial cells were used as
neutrophil activation, hyperoxia, metabolism of redox-active target cells in this study,because the vascular endothelium is
a significantsite of oxidant injury (12)and because the
* This work wassupported by National Institutes of Health Grants anatomical localization of the vascular endothelium provides
NS-23700 and NS-24275 (to B. A. F.), HL-28182 (to J. E. R.), and
HL-33550 (to G . M.R.) and by grants from the Health Effects
direct contact with circulating antioxidant enzymes. We re-
Institute (to B. A. F.) and the Alabama Affiliate of the American
Heart Association (to J. S. B.). The costs of publication of this article ’ The abbreviations used are: PEG, polyethylene glycol; FITC,
were defrayed in part by the payment of page charges. This article fluorescein isothiocyanate; HBSS, Hank’s balanced salt solution;
must therefore be hereby marked “advertisement” in accordance with Mal-6-TEMPO, 3-maleimido-2,2,6,6,-tetramethylpiperidinooxy~ W/
18 U.S.C. Section 1734 solelyto indicate this fact. S ratio, the weakly to strongly immobilized peak ratio.
6884
0
0 0
I I I I
0 30 120 60 90
18
t
16
14
e
12
X
Y
0 2 4
TIME (HR)
FIG. 3. Augmentation of endothelial cell catalase specific
21
brane protein mobility are inhibitable by superoxide dismu- FIG. 4. The radioactivity associated with endothelial cell
tase (23). monolayers incubated with 0.5 mg/ml medium of 'aaI-labeled
PEG-catalase (W) and lZsI-catalase(0).These values were meas-
The release of 51Crinto culturemedium from cells following ured in cell incubations reported in Fig. 3.
injury is analogous to the release of endogenous lactate de-
hydrogenase (27, 28). Control experiments showed that incu-
bation of PEG-superoxide dismutase or PEG-catalase(1 mg/ with concentrations of0.5 or 1.0 mg of PEG-catalase/ml
ml) with endothelial cells for 24 h(without exposure to medium for 24 h and washed free of enzyme-containing me-
xanthine plus xanthine oxidase) did not enhance 51Crrelease dium before xanthine oxidase exposure prevented 80% of the
from endothelial cells. Under the experimental conditions we 51Crrelease compared with untreated controls. Preincubation
employed, exposure to 10 milliunits of xanthine oxidase/ml with 0.5 or 1.0 mg of native catalase/ml medium reduced 'lCr
medium plus 0.1 mM xanthine induced lysis or detachmentof to a lesser extent. Addition of 1%PEG in the presence or
85% of the monolayer. Augmentation of endothelial cell cat- absence of native catalase (0.5 mg/ml) did not affect the
alase activity after 24 h preincubation with PEG-catalase amount of 51Crrelease compared with untreated cells.
increased resistance of endothelial cells to lysis induced by The protection provided by preincubation of cells with
xanthine oxidase (Fig. 8). Endothelial cell cultures incubated native catalase might bedue to the apparent electrostatic
6888 Augmenting EndothelialEnzymes
Antioxidant
TABLE I1
Percentages of enzyme added to the medium which was taken up by
endothelial cell monolayers after 24-hincubation
The catalase data were derived fromthe experiment shown in Figs.
3 and 4, while the superoxide dismutase data came from Fig. 6.
Percentage uptake
Enzyme Radio-
activity activity
PEG-catalase 0.07 0.12
Catalase 0.01 0.20
PEG-superoxide dismutase
0.10 0.13
Superoxide dismutase 0.01 0.04
I 1 I
0 8 16 24
100
i
80
W
v)
a
w
-I
E 60
6
Lo
8
40
20
a
0 .5 1
[CATALASE]
FIG. 8. Increasedendothelial cell resistance to oxidant
stress followingtreatmentwithPEG-catalase. Endothelial
monolayers were prelabeled with %r and then incubated for 24 h
with 0.5 mg/ml either native (0) or PEG-catalase (M). The cell
monolayers were then washed five times and placed in HBSS. Xan-
thine oxidase (10 milliunits/ml) and xanthine (100 PM) were added
to themedium and therelease of 51Crby cells was measured 4 hlater.
Each point represents the mean f S.E. of eight replicates. At concen-
trations a t and above 0.4 mg/ml, the differences in 51Crrelease
between PEG-catalase- and catalase-treated cells were significantly
different at the0.05 level.
15
r t 1% PEG + PEG-SOD
FIG. 10. The effect ofpretreatment of endothelial cells with
1 mg/ml PEG-superoxide dismutase (SOD) or with 1% PEG
on the rate of change in the W/S ratio following exposure to
12.5 xanthine oxidase plus xanthine. Cell exposures also had native
superoxide dismutase (300 units/ml) added directly to the cuvette
(open bars) to establish the maximum protection that could be pro-
vided by superoxide dismutase. Reaction conditions for exposure to
xanthine oxidase are described in Fig. 9. The rates of change in the
10
W/S ratio were determined by linear regression, and the standard
errors of the slopes are shown.
0
c-
a 7.5
The binding of PEG-enzymes to cell membranes does not
U explain the continuous uptake of enzyme conjugates by endo-
cn thelial cells over 24 h because the binding of PEG to mem-
5 branes shouldbe rapidly saturated (11).
5 The third explanation entails the uptake of PEG-conju-
gated enzymes by endocytosis from themedium. In confluent
stationary phase bovine aortic endothelial cells, the rate of
medium uptake by endocytosis is reported tobe 50 nl h"/106
2.5 cells (26). If we assume that this rateof endocytosis is similar
in cultured porcine endothelium and take into account cell
number and medium volume, between 0.06 and 0.09% of the
medium would be taken up by cells by endocytosis in 24 h.
0 1 1 I 1 I I The fraction of cellular uptake of both PEG-superoxide dis-
0 2 4 6 8 10 12 mutaseandPEG-catalasepresentinculture medium was
0.07-0.13% in 24 h (Table 11), consistent with the calculated
TIME (MIN) rate of uptake by endocytosis. The punctate distribution of
FIG. 9. A, the EPR spectrum of Mal-6-TEMPO-labeled endothe- fluorescence observed inendothelial cells incubated with
lial cells is shown. B, the time-dependent changes in the W/S ratio FITC-labeled PEG-superoxide dismutasealso suggests that a
are shown for control cells (O),cells exposed to xanthine oxidase (10
milliunits/ml) plus 100 pM xanthine (+), cells pretreated with 1% vesicular uptake process plays a major role in the uptake of
PEG and exposed to xanthine oxidase plus xanthine (A),and cells PEG-conjugated proteins. Mechanical injury to the mono-
incubated in the presence of 300 units/ml superoxide dismutase and layer, known to stimulate endocytosis (26), considerably aug-
xanthine plus xanthine oxidase (m). The lines were fit by linear mented the uptakeof FITC-PEG-superoxide dismutase, sup-
regression. porting endocytosis as a contributing factor in uptake of PEG-
conjugated enzymes.
that enough hydrophilicresidues aremasked by PEG to The difference in the rate of native and PEG-conjugated
permitan otherwisehydrophilic proteintopartitioninto enzyme uptake by endocytosis can be explained by the in-
hydrophobic solvents (30). While PEG itself is quite soluble creased resistance of PEG-conjugated enzymes to proteolysis.
in aromatic solvents such as benzene, it precipitates rapidly Because PEG-protein conjugates are resistant to proteases
in alkane solvents, a fact made use of in the synthesis of (7), they can survive within lysosomes, yielding higher cell-
activatedPEG forcoupling toproteins(7).Hence,PEG- associated specific activities. Native catalase added to either
derivatized enzymes would not be expected to be soluble crude endothelial cell lysates or delivered to endothelial cells
within the aliphatic core of phospholipid membranes and via liposomes is degraded with a half-life of 2-3 h (31). On
therefore areunlikely to traverse the membranecore. the other hand, superoxide dismutase is more resistant to
Polyethylene glycol avidly associates with membranes in proteolysis and liposome-delivered superoxide dismutase was
the phospholipid headgroup region ( l l ) , which might allow far more stable in endothelial cells than catalase (20). How-
anchoring of PEG-conjugated proteins to exofacial plasma ever, Cu,Zn superoxide dismutase loses its zinc cofactor when
membrane surfaces. Evidence in favor of this concept is the exposed to an acidic pH and becomes susceptible to protease
increased W/S ratio of Mal-6-TEMPO-treated endothelial degradation (32). Thus, native superoxide dismutase present
membranessecondarytoincubationwithPEG-superoxide in acidic endosomal and lysosomal compartments should be
dismutase, suggestingsomeinfluence is exertedupon cell degraded. Inthepresentstudy, degradation of both cell-
membranes by superoxide dismutase after PEG conjugation. associated native superoxide dismutase and catalasewas ob-
Augmenting EndothelialEnzymes
Antioxidant 6891
served, as evidenced by the continuous increase in the ratio tation of cellular antioxidant activities. Furthermore, areasof
of counts/min of Iz5I/unitenzyme in cells incubated with lZ5I- reversibly injured endothelium in vivo may concentrate even
labeled proteins (Figs. 4 and 6). Thisratio for PEG-superoxide greater levels of PEG-conjugated enzymes due to injury-
dismutase- and catalase-treated cells remained almost the enhanced endocytic processes (26).
same as thespecific activity of the PEG-superoxide dismutase Our results suggest that anadditional consequence of PEG-
and PEG-catalase added to the medium, even after 24 h of conjugation to proteins is the enhancement of protein asso-
incubation with the endothelial cells. ciation with cells. Uptake of PEG-conjugated enzymes by
On balance, there is evidence to support cell uptake of other cell types almost certainly will occur in uiuo as well.
PEG-enzymes by both membrane binding and endocytosis. The prolonged treatment with PEG-conjugated adenosine
These two explanations are not mutually exclusive and could deaminase in children afflicted with severe combined immu-
even complement each other. For example, the binding of nodeficiency disease due to adenosine deaminase deficiency
PEG-enzymes to cell surfaces may enhance endocytosis, led to restoration of immune function after 6 months (37).
thereby increasing rates of endocytic uptake. Further studies Conceivably, uptake of PEG-adenosine deaminase by imma-
are required to differentiate between PEG-enzyme uptake by ture lymphocytes may have contributed to the intracellular
endocytic bulk phase transport of protein conjugates in solu- removal of inhibitory metabolites in addition to those secreted
tion, or the internalization of PEG-enzymes bound to plasma into plasma, enabling these cells to differentiate and restore
membrane, whichwould then be distributedin endocytic immune function.
vacuoles and throughout the cell by membrane flow (33).
Acknowledgments-Both Diagnostic Data Inc. (Mountain View,
Can PEG-conjugated antioxidant enzymes entrapped CA) and Grunenthal GmbH (Aachen, Germany) generously provided
within endosomes or lysosomes also provide protection Cu,Zn superoxide dismutase for these studies. We thank Zermeena
against intracellularly generated superoxide and hydrogen Mirza and M. Kathy Cunningham for their expert assistance in the
peroxide, since these enzymes are separated from the cyto- culture of endothelial cells.
plasm by a membrane barrier? Endosomes and lysosomes
REFERENCES
become strongly acidic by an active proton pumping mecha-
nism that requires the presence of an anion channel which 1. Beckman, J. S., and Freeman, B. A. (1986)in Physiology of Oxygen
Radicals (Taylor, A., and Matalon, S., eds) pp. 39-53, American
allows migration of chloride ions to counterbalance proton Physiological Society, Bethesda, MD
accumulation within the endosome (34). Because anion chan- 2. Freeman, B. A., and Crapo, J. D. (1982) Lab. Znuest. 47,412-426
nels permit migration of superoxide across red blood cell 3. Taylor, A. E., and Martin, D. J. (1983) Physiologist 26,152-155
membranes (35), it is possible that PEG-superoxide dismutase 4. Petkau, A., Chelack, W. S., Kelly, K., Barefoot, C., and Monas-
entrapped within lysosomes or endosomes could act as a sump terski, L. (1976) Res. Commun. Chem. Pathol. Phnrmacol. 15,
for intracellular superoxide radicals which traverse the chlo- 641-657
5. Turrens, J. F., Crapo, J. D., and Freeman, B. A. (1984) J. Clin.
ride anion channel. Recently, Saez et al. (36) have shown that Invest. 73,87-95
native superoxide dismutase added to themedium of cultured 6. Hutchinson, F. (1957) Radiat. Res. 7,473-483
superior cervical ganglion neurons is rapidly taken up by 7. Abuchowski, A., van Es, T., Palczuk, N. C., and Davis, F. F.
endocytosis after the cells are transiently depolarized with (1977) J. Biol. Chem. 252,3578-3581
potassium chloride. These neurons, which had superoxide 8. Abuchowski, A., McCoy, J. R., Palczuk, N., Van Es,T.,and
Davis, F. F. (1977) J. Bid. Chem. 252,3582-3586
dismutase entrapped within an endocytic compartment, were 9. Pyatak, P. S., Abuchowski,A,, and Davis, F.F. (1980) Res.
more resistant to a 40-min starvation stress, whereas starved Commun. Chem. Pathol. Phnrmacol. 29, 113-127
neurons that were not depolarized but had superoxide dis- 10.Wojcieszyn, J. W., Schlegel, R.A., Lumley-Sapanski, K., and
mutase added to themedium were not protected. Jacobson, K. A. (1983) J. Cell Biol. 96,151-159
The increased activity of PEG-conjugated enzymes ob- 11. Boni, L. T., Hah, J. S., Hui, S. W., Mukherjee, P., Ho, J. T., and
Jung, C. Y.(1984) Biochem. Biophys. Acta 775,409-418
served in cultured endothelial cells suggests that prolonged 12. Taylor, A. E., and Martin, D. J. (1983) Physiologist 26,152-155
administration of PEG-conjugated enzymes may gradually 13. McCord, J. M.,and Fridovich, I. (1969)J. Biol. Chem. 244,6049-
augment vesicular-associated cell antioxidant enzyme activi- 6055
ties in uiuo, implying a more complex pharmacokinetics than 14. Bergmeyer, H.R. (1963)Methods of Enzymatic Analysis,pp. 885-
reflected by plasma clearance. Although the uptake of PEG- 888, Academic Press, NY
superoxide dismutase and PEG-catalase by endothelium re- 15. Fridovich, I. (1970) J. Biol. Chem. 245,4053-4057
16. Biagioni, S. (1978)Anal. Biochem. 89, 616-622
ported here is a slow process, the continual exposure of 17. Habeeb, A. F. S. A. (1966) Anal. Biochem. 14, 328-336
endothelium to PEG-conjugated enzymes having long circu- 18. Fraker, P. J., andSpeck, J. C., Jr. (1978) Biochem. Biophys. Res.
latory half-lives and stability may lead to significant augmen- Commun. 80,849-857
6892 Augmenting EndothelialEnzymes
Antioxidant
19. Rinderknecht, H. (1962) Nature 93, 167-169 29. Tanswell, A. K., and Freeman, B. A. (1987) J. Appl. PhysioL 63,
20. Freeman, B. A., Young, S. L., and Crapo, J. D. (1983) J. Biol. 347-352
Chem. 258, 12534-12542 30. Takahashi, K., Nishimura, H., Yoshimoto, T., Saito, Y., and
21. Bishop, C. T., Mirza, Z., Crapo, J. D., and Freeman, B. A. (1985) Inada, Y. (1984) Biochem. Biophys. Res. Commun. 121, 261-
Zn Vitro 21,229-236 265
22. Lowry, 0.H., Rosebrough, N. J., Farr, A. J., and Randall, R. J. 31. Freeman, B. A. (1988) Biochem. Pharrnacol., in press
(1951) J. Biol. Chern. 193,265-275 32. Forman, H. J., and Fridovich, I. (1973)J.Biol. Chern. 248,2645-
23. Freeman, B. A,, Rosen, G. M.. and Barber, M. J. (1986) J. Biol. 2649
Chem. 26 1,6590-6593 33. Steinman, R. M., Mellman, I. S., Muller, W. A., and Cohn, Z. A.
24. Sokal, R. R., and Rohlf, F. J. (1981) Biometry, 2nd Ed. pp. 507- (1983)J. Cell. Biol. 96, 1-27
509, W. H. Freeman Co., NY 34. Stahl, P., and Schwartz, A. L. (1986)J. Clin. Znuest. 77,657-662
25. Wallerstein, S., Zucker, C. L., and Fleiss, J. L. (1980) Circ. Res. 35. Kellogg, E. W., 111, and Fridovich, I. (1977) J. Biol. Chem. 252,
47,l-9 6721-6728
26. Davies, P. F., Selden, S. C., and Schwartz, S. M. (1980) J. Cell. 36. Saez, J. C., Kessler, J. A., Bennett, M. V. L., and Spray, D. C.
Physiol. 102,119-127 (1987) Proc. Natl. Acad. Sci. U. S. A . 84, 3057-3059
27. Andreoi, S. P., Baehner, R. L., and Bergstein, J. M. (1985) J. 37. Herschfield, M. S., Buckley, R. H., Greenberg, M. L., Melton, A.
Clin. Invest. 106, 253-261 L., Schiff, R., Hatem, C., Kurtzberg, J., Markert, M. L., Ko-
28. Freeman, B. A., Turrens, J. F., Mirza, Z., Crapo, J. D., and Young, bayashi, R. H., Kobayashi, A. L., and Abuchowski, A. (1987)
S. L. (1985) Fed. Proc. 44, 2591-2595 N . Engl. J. Med. 316, 589-596